Author:
Toloza Sergio M. A.,Uribe América G.,McGwin Gerald,Alarcón Graciela S.,Fessler Barri J.,Bastian Holly M.,Vilá Luis M.,Wu Ruihua,Shoenfeld Yehuda,Roseman Jeffrey M.,Reveille John D.,
Funder
NIH
The Mary Kirkland Scholar Award Program
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference62 articles.
1. The use of hydroxychloroquine in the prevention of thrombosis in systemic lupus erythematosus;Ho;Arthritis Rheum,2003
2. Hydroxychloroquine (HCQ) usage is associated with decreased renal and cardiovascular damage in patients with systemic lupus erythematosus (SLE);Fessler;Arthritis Rheum,2001
3. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus;Roman;N Engl J Med,2003
4. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis;Petri;Am J Med,1994
5. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus;Boumpas;Ann Intern Med,1990
Cited by
267 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献